polycystic ovary syndrome |
13 |
anti-müllerian hormone |
12 |
fatty liver disease |
11 |
female |
11 |
in vitro fertilization |
11 |
mafld (metabolic associated fatty liver disease) |
11 |
obesity |
11 |
overweight |
11 |
population based study |
11 |
tubal ectopic pregnancy |
11 |
dysglycaemia |
10 |
humans |
10 |
infertility |
10 |
ovarian response |
10 |
male |
9 |
adrenomedullin |
8 |
adrenomedullin - genetics - metabolism |
8 |
anti-mullerian hormone |
8 |
calcitonin receptor-like protein |
8 |
cell communication - physiology |
8 |
cell line |
8 |
cilia - metabolism - physiology |
8 |
epithelium - metabolism - physiology |
8 |
fallopian tubes - metabolism |
8 |
gene expression regulation - drug effects |
8 |
hormones - metabolism - pharmacology |
8 |
intracellular signaling peptides and proteins - genetics - metabolism |
8 |
intrauterine insemination |
8 |
membrane proteins - genetics - metabolism |
8 |
menstrual cycle - genetics - metabolism - physiology |
8 |
models, biological |
8 |
receptor activity-modifying proteins |
8 |
receptors, calcitonin - genetics - metabolism |
8 |
spermatozoa - metabolism - physiology |
8 |
ulipristal acetate |
8 |
age‐specific reference range |
7 |
anti‐müllerian hormone |
7 |
antral follicle count |
7 |
automated chemiluminescence assay |
7 |
chemokines |
7 |
chinese women |
7 |
ciliary beat frequency |
7 |
endometrial regeneration |
7 |
endometrial stem cells |
7 |
fallopian tube |
7 |
inflammatory cytokines |
7 |
mifepristone |
7 |
nasal ciliated epithelium |
7 |
pregnancy |
7 |
randomized controlled trial |
7 |
spermatozoa |
7 |
vitamin d |
7 |
apoptosis |
6 |
biological markers - blood |
6 |
cell biology |
6 |
cell signaling |
6 |
chemotherapy |
6 |
cumulative live birth rate |
6 |
endometrium |
6 |
fasting glucose |
6 |
frozen embryo transfer |
6 |
gestational trophoblastic neoplasia |
6 |
leptin |
6 |
leptin receptor |
6 |
letrozole |
6 |
mapk signaling |
6 |
medical abortion |
6 |
miscarriage |
6 |
misoprostol |
6 |
molar pregnancy |
6 |
obstetrics and gynecology |
6 |
olfactomedin-1 |
6 |
oral glucose tolerance test |
6 |
ovarian reserve |
6 |
pain relief |
6 |
pregnancy rate |
6 |
progesterone receptor |
6 |
stem cell-microenvironment interactions |
6 |
stromal cells |
6 |
wnt-signaling |
6 |
25-hydroxyvitamin d |
5 |
adiposity |
5 |
adolescent |
5 |
adult |
5 |
age |
5 |
androgen |
5 |
anti-mullerian hormone - blood |
5 |
anti‐mullerian hormone |
5 |
birth control medical sciences |
5 |
cancer |
5 |
ciliary beat |
5 |
down syndrome |
5 |
down syndrome - blood |
5 |
embryo cryopreservation |
5 |
embryo transfer |
5 |
emergency contraception |
5 |
endometrial attachment |
5 |
endothelial cell |
5 |
fertility preservation |
5 |
fertilization in vitro |
5 |
frozen-thawed embryo transfer |
5 |
gestational age |
5 |
glycodelin |
5 |
gonadotrophin dosing |
5 |
human fallopian tube |
5 |
in vitro fertilsation |
5 |
ishikawa cell line |
5 |
ivf |
5 |
l-selectin |
5 |
live birth |
5 |
maternal age |
5 |
medical sciences |
5 |
middle aged |
5 |
muscular contraction |
5 |
natural cycle |
5 |
natural killer cell |
5 |
oocyte cryopreservation |
5 |
pregnancy - blood |
5 |
primary endometrial cell culture |
5 |
progesterone elevation |
5 |
sperm cryopreservation |
5 |
threatened miscarriage |
5 |
trophoblast |
5 |
abortifacient agents, nonsteroidal - pharmacokinetics |
4 |
abortion, induced - methods |
4 |
acetic acid |
4 |
acetic acid - pharmacokinetics |
4 |
acrosome reaction |
4 |
acrosome reaction - drug effects - physiology |
4 |
advanced glycation end-products |
4 |
anti-mullerian hormone - analysis - blood |
4 |
anti-möllerian hormone |
4 |
anti-obesity drugs |
4 |
antimullerian hormone |
4 |
attitude |
4 |
automated chemiluminescence |
4 |
capacitation |
4 |
cell count |
4 |
chinese couple |
4 |
chlortetracycline - metabolism - pharmacology |
4 |
combined injectable contraceptive |
4 |
combined oral contraceptive |
4 |
concern |
4 |
conscious sedation |
4 |
contraceptives, oral, combined - pharmacology |
4 |
controlled ovarian stimulation |
4 |
counselling |
4 |
cryopreservation |
4 |
cumulative live birth |
4 |
cumulative live-birth |
4 |
dhea |
4 |
dilution linearity |
4 |
diminished ovarian reserve |
4 |
dna integrity |
4 |
dna meiotic recombinase 1 (dmc1) |
4 |
dydrogesterone |
4 |
endocrinology |
4 |
endocrinology pharmacy and pharmacology |
4 |
endometrial injury |
4 |
enzyme-linked immunosorbent assay |
4 |
family planning service provision |
4 |
fertilization |
4 |
first trimester |
4 |
freeze-thaw stability |
4 |
granulosa cells |
4 |
hcg |
4 |
homozygous frameshift mutation |
4 |
hspa2 |
4 |
human spermatozoa |
4 |
human study |
4 |
hyaluronic acid |
4 |
hydrogen-ion concentration |
4 |
hyperprolactinemia |
4 |
hypogonadotrophic hypogonadism |
4 |
immunoassay |
4 |
in vitro activation |
4 |
in vitro fertilisation |
4 |
in-vitro fertilisation |
4 |
infertility - blood - diagnosis - therapy |
4 |
inhibin b |
4 |
inhibins - blood |
4 |
insemination, artificial - methods |
4 |
interleukin 6 |
4 |
intervention |
4 |
intrauterine devices, medicated |
4 |
intrauterine lidocaine |
4 |
isolated polycystic ovaries |
4 |
leptin - metabolism - pharmacology |
4 |
levonorgestrel intrauterine system |
4 |
lidocaine gel |
4 |
live birth rate |
4 |
live-birth |
4 |
luteal phase support |
4 |
macrophages |
4 |
male germline-specific protein |
4 |
maps |
4 |
meiosis prophase i |
4 |
mental health |
4 |
metabolic syndrome |
4 |
metformin |
4 |
method comparison |
4 |
methylation |
4 |
misoprostol - pharmacokinetics |
4 |
motility |
4 |
mouse study |
4 |
natural cycles |
4 |
natural family planning |
4 |
nonobstructive azoospermia |
4 |
normal ovarian responders |
4 |
normal saline |
4 |
obstetrics and gynecology medical sciences |
4 |
oligomenorrhea - blood - diagnosis - etiology |
4 |
oocyte |
4 |
oogenesis |
4 |
oral progestogen |
4 |
orlistat |
4 |
ovarian response markers |
4 |
ovarian response prediction index |
4 |
ovulation induction - adverse effects - methods |
4 |
pachynema progression |
4 |
pharmacokinetics |
4 |
pi3k/pten signaling |
4 |
poor responders |
4 |
pre-pregnancy |
4 |
precision |
4 |
preimplantation genetic testing |
4 |
premature ovarian failure |
4 |
primordial follicles |
4 |
progesterone |
4 |
progestins - pharmacology |
4 |
progestogen |
4 |
progestogen-only injectable |
4 |
progestogen-only pill |
4 |
prospective studies |
4 |
protamination |
4 |
randomised trial |
4 |
saline contrast sonohysterography |
4 |
saline infusion sonogram |
4 |
semen - metabolism |
4 |
sexual dimorphism |
4 |
sibutramine |
4 |
soluble receptor of advanced glycation end-products |
4 |
spaca3 |
4 |
sperm capacitation - drug effects |
4 |
sperm motility - drug effects - physiology |
4 |
sperm selection |
4 |
spermatogenesis |
4 |
spermatozoa - drug effects - metabolism - physiology |
4 |
stem cell niche |
4 |
t cell |
4 |
transfer medium |
4 |
vaginal bleeding |
4 |
vaginal misoprostol |
4 |
whole-exome sequencing |
4 |
wnt/β-catenin signaling |
4 |
zona pellucida |
4 |
4930432k21rik |
3 |
adrenomedullin - blood - genetics - physiology |
3 |
antiobesity drugs |
3 |
arthritis |
3 |
arthritis, rheumatoid |
3 |
cilia - physiology |
3 |
continuous companion support |
3 |
contraceptives |
3 |
contraceptives, oral, combined |
3 |
contraceptives, oral, hormonal |
3 |
cost |
3 |
covid-19 pandemic |
3 |
creb |
3 |
dehydroepiandrosterone |
3 |
erectile dysfunction |
3 |
fallopian tubes - physiology |
3 |
female sexual dysfunction |
3 |
fertility restoration |
3 |
follicle-stimulating hormone |
3 |
hormonal |
3 |
hormone replacement therapy |
3 |
in-vitro fertilization |
3 |
labyrinthine zone |
3 |
lorcaserin |
3 |
lupus erythematosus |
3 |
lupus erythematosus, systemic |
3 |
meiosis |
3 |
menstrual pattern |
3 |
mtor |
3 |
oral |
3 |
ovarian sensitivity index |
3 |
ovarian stimulation |
3 |
phentermine/topiramate |
3 |
placenta |
3 |
post-ovulatory |
3 |
pre-ovulatory |
3 |
pregnancy outcomes |
3 |
pregnancy, tubal - blood - etiology - physiopathology |
3 |
premature ovarian insufficiency |
3 |
prepregnancy |
3 |
public service |
3 |
quality of life. |
3 |
recombination |
3 |
rheumatic diseases |
3 |
rheumatoid |
3 |
systemic |
3 |
testosterone |
3 |
tlr5 |
3 |
transcutaneous electrical nerve stimulation |
3 |
transvaginal oocyte retrieval |
3 |
ubiquitination |
3 |
waiting time |
3 |
willingness to pay |
3 |
3-dimensional |
2 |
acupuncture |
2 |
amh |
2 |
anovulatory subfertility |
2 |
anti-oestrogen |
2 |
aromatase inhibitor |
2 |
atosiban |
2 |
automated assays |
2 |
box trainer |
2 |
caesarean scar |
2 |
choriocarcinoma |
2 |
choriocarcinoma - metabolism |
2 |
companion diagnostic |
2 |
controlled ovarian hyperstimulation |
2 |
copper intrauterine device |
2 |
de novo mutation |
2 |
dopamine agonist |
2 |
droplet digital pcr |
2 |
early pregnancy assessment clinic |
2 |
ectopic pregnancy |
2 |
follitropin delta |
2 |
gonadal mosaicism |
2 |
gonadotrophin |
2 |
gonosomal mosaicism |
2 |
hydatidiform mole |
2 |
hydatidiform mole - metabolism |
2 |
immunoassays |
2 |
immunohistochemistry |
2 |
infertility. |
2 |
insulin resistance |
2 |
insulin sensitivity |
2 |
ipd meta-analysis |
2 |
laparoscopy |
2 |
leptin - biosynthesis |
2 |
levonorgestrel |
2 |
obstetric outcomes |
2 |
oocyte retrieval |
2 |
ovarian drilling |
2 |
parental mosaicism |
2 |
pcos |
2 |
personalised medicine |
2 |
placenta - metabolism |
2 |
placental site trophoblastic tumor |
2 |
protein isoforms |
2 |
pulsatile gnrh |
2 |
receptors, cell surface - biosynthesis |
2 |
receptors, leptin |
2 |
recurrence risk |
2 |
reverse transcriptase polymerase chain reaction |
2 |
stein-leventhal syndrome. |
2 |
up-regulation |
2 |
uterine contraction |
2 |
uterine neoplasms - metabolism |
2 |
weight management |
2 |
早孕 |
2 |
米索前列醇 (misoprostol) |
2 |
米非司酮 (mifepristone) |
2 |
舌下含服 (sublingual swallowing) |
2 |
药物流产 |
2 |
abortion |
1 |
adipocyte |
1 |
administration, intravaginal |
1 |
anesthetics, local - administration & dosage |
1 |
anovulation - drug therapy |
1 |
antineoplastic combined chemotherapy protocols - adverse effects |
1 |
artificial insemination |
1 |
asia-oceania |
1 |
asian women |
1 |
assisted conception |
1 |
assisted reproduction |
1 |
assisted reproductive technology |
1 |
automated chemiluminescence immunoassay |
1 |
beta-adrenergic receptor signaling |
1 |
biopsy, needle - adverse effects |
1 |
carmustine - adverse effects |
1 |
case-control studies |
1 |
cervical punch biopsy |
1 |
cisplatin - adverse effects |
1 |
colposcopy |
1 |
colposcopy - adverse effects |
1 |
combination chemotherapy |
1 |
combined oral contraceptive pills |
1 |
contraception |
1 |
contraception - statistics & numerical data |
1 |
contraceptive agents, female |
1 |
contraceptive benefits |
1 |
contraceptive failure |
1 |
contraceptive safety |
1 |
corpus luteum |
1 |
cumulative ongoing pregnancy |
1 |
dacarbazine - adverse effects |
1 |
dna primers |
1 |
double-blind method |
1 |
endometrial effect |
1 |
endometrioid adenocarcinoma |
1 |
enzyme-linked immunosorbent assay (elisa) |
1 |
family planning services |
1 |
female sterilization |
1 |
follicle stimulating hormone, human - therapeutic use |
1 |
gels |
1 |
gene expression profiling |
1 |
health services accessibility |
1 |
hong kong - epidemiology |
1 |
human |
1 |
hyperandrogenism - blood - complications - epidemiology |
1 |
implantation |
1 |
induced |
1 |
infant, newborn |
1 |
infertility, female - drug therapy |
1 |
injectable contraceptive |
1 |
international standard |
1 |
intrauterine contraceptive device |
1 |
lidocaine - administration & dosage |
1 |
lignocaine gel |
1 |
lipogenesis |
1 |
lipolysis |
1 |
liver neoplasms - drug therapy - secondary |
1 |
long-acting reversible contraception |
1 |
maspin |
1 |
melanoma |
1 |
melanoma - drug therapy - secondary |
1 |
metabolic syndrome x - blood - epidemiology - etiology |
1 |
metastasis |
1 |
microphthalmos |
1 |
microphthalmos - chemically induced |
1 |
npy |
1 |
obesity - blood - complications - epidemiology |
1 |
ovulation induction |
1 |
ovulation induction - methods |
1 |
pain - prevention & control |
1 |
pain measurement |
1 |
pilot projects |
1 |
polycystic ovary syndrome - blood - complications - epidemiology |
1 |
postcoital contraceptive agents |
1 |
pre-eclampsia - metabolism |
1 |
preeclampsia |
1 |
pregnancy complications |
1 |
pregnancy complications, neoplastic - drug therapy |
1 |
pregnancy trimester, first - drug effects |
1 |
pregnancy trimester, second - drug effects |
1 |
prevalence |
1 |
protein isoforms - biosynthesis |
1 |
quality of life |
1 |
questionnaires |
1 |
reference preparation |
1 |
reproductive health |
1 |
retrospective studies |
1 |
risk factors |
1 |
scotland - epidemiology |
1 |
sexual function |
1 |
sexuality |
1 |
skin neoplasms - drug therapy - pathology |
1 |
sterilization, tubal |
1 |
suction evacuation |
1 |
tamoxifen - adverse effects |
1 |
termination of pregnancy |
1 |
topical xylocaine gel |
1 |
vitamin d - analogs & derivatives - blood |
1 |
vitamin d deficiency - blood - complications - epidemiology |
1 |
young adult |
1 |